ImmunityBio (IBRX) Times Interest Earned (2016 - 2026)
ImmunityBio (IBRX) reported Times Interest Earned of -$4.78 for Q1 2026, down 13.67% year-over-year from -$5.54 in Q1 2025, and down 9.75% on a QoQ basis from -$4.36 in Q4 2025.
ImmunityBio (IBRX) has 10 years of Times Interest Earned data on file, last reported at -$4.78 in Q1 2026.
- Quarterly Times Interest Earned fell 13.67% year-over-year to -$4.78 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.34 (down 39.23% YoY) and the FY2025 annual result came in at -$4.21, down 40.0% from the prior year.
- Times Interest Earned eased to -$4.78 in Q1 2026 per IBRX's latest filing, from -$4.36 in the prior quarter.
- Across five years, Times Interest Earned topped out at $4.55 in Q4 2022 and bottomed at -$213.47 in Q4 2023.
- The 5-year median for Times Interest Earned is -$3.74 (2023), against an average of -$16.24.
- The widest annual swing landed in 2022, when Times Interest Earned soared 125.78%; it then sank 4790.11% in 2023.
- Tracing IBRX's Times Interest Earned over 5 years: stood at $4.55 in 2022, then slumped by 4790.11% to -$213.47 in 2023, then surged by 98.75% to -$2.67 in 2024, then slumped by 63.39% to -$4.36 in 2025, then dropped by 9.75% to -$4.78 in 2026.
- Per Business Quant, the three latest IBRX Times Interest Earned figures stand at -$4.78 (Q1 2026), -$4.36 (Q4 2025), and -$3.65 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -4.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.78 |
| Dec 31, 2025 | -4.36 |
| Sep 30, 2025 | -3.65 |
| Jun 30, 2025 | -4.61 |
| Mar 31, 2025 | -4.21 |
| Dec 31, 2024 | -2.67 |
| Sep 30, 2024 | -2.74 |
| Jun 30, 2024 | -3.33 |
| Mar 31, 2024 | -3.23 |
| Dec 31, 2023 | -213.47 |
| Sep 30, 2023 | -2.29 |
| Jun 30, 2023 | -2.64 |
| Mar 31, 2023 | -3.74 |
| Dec 31, 2022 | 4.55 |
| Sep 30, 2022 | -5.42 |
| Jun 30, 2022 | -8.21 |
| Mar 31, 2022 | -11.30 |
| Dec 31, 2021 | -17.66 |
| Sep 30, 2021 | -21.81 |
| Jun 30, 2021 | -24.02 |
| Mar 31, 2021 | -27.23 |
| Dec 31, 2020 | -10.89 |
| Sep 30, 2020 | -29.59 |
| Jun 30, 2020 | -23.98 |
| Mar 31, 2020 | -19.43 |
| Mar 31, 2018 | -857.09 |
| Dec 31, 2017 | -746.88 |
| Sep 30, 2017 | -62.19 |
| Jun 30, 2017 | -154.68 |
| Mar 31, 2017 | -688.22 |
| Dec 31, 2016 | -679.54 |
| Sep 30, 2016 | -1,130.17 |